Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_assertion type Assertion NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_head.
- NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_assertion description "[Highly invasive human prostate cancer cells PC-3 were treated with either the methyl donor S-adenosylmethionine (SAM) or methyl DNA-binding domain protein 2 antisense oligonucleotide (MBD2-AS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_provenance.
- NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_assertion evidence source_evidence_literature NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_provenance.
- NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_assertion SIO_000772 16982764 NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_provenance.
- NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_assertion wasDerivedFrom befree-2016 NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_provenance.
- NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_assertion wasGeneratedBy ECO_0000203 NP569898.RAVoJSRrUhTrUXpzK4iKu09InRdQDnGsJbxVbr24Pg45Q130_provenance.